>
Switch to:

Allergy Therapeutics Total Assets

: $123.5 Mil (As of Jun. 2021)
View and export this data going back to 2004. Start your Free Trial

Allergy Therapeutics's Total Assets for the quarter that ended in Jun. 2021 was $123.5 Mil.

Warning Sign:

If a company builds asset at 8.9% a year, faster than its revenue growth rate of 6.3% over the past 5 years, it means that the company may be getting less efficent.

During the past 12 months, Allergy Therapeutics's average Total Assets Growth Rate was -2.90% per year. During the past 3 years, the average Total Assets Growth Rate was 10.50% per year. During the past 5 years, the average Total Assets Growth Rate was 8.90% per year. During the past 10 years, the average Total Assets Growth Rate was 6.40% per year.

During the past 13 years, Allergy Therapeutics's highest 3-Year average Total Assets Growth Rate was 23.20%. The lowest was -3.80%. And the median was 10.00%.

Total Assets is connected with ROA %. Allergy Therapeutics's annualized ROA % for the quarter that ended in Jun. 2021 was -26.35%. Total Assets is also linked to Revenue through Asset Turnover. Allergy Therapeutics's Asset Turnover for the quarter that ended in Jun. 2021 was 0.33.


Allergy Therapeutics Total Assets Historical Data

The historical data trend for Allergy Therapeutics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergy Therapeutics Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Total Assets
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 73.22 67.84 86.81 107.92 123.55

Allergy Therapeutics Semi-Annual Data
Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21
Total Assets Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 86.81 115.23 107.92 133.07 123.55

Allergy Therapeutics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Allergy Therapeutics's Total Assets for the fiscal year that ended in Jun. 2021 is calculated as

Total Assets=Total Equity (A: Jun. 2021 )+Total Liabilities (A: Jun. 2021 )
=68.071528751753+55.475455820477
=123.5

Allergy Therapeutics's Total Assets for the quarter that ended in Jun. 2021 is calculated as

Total Assets=Total Equity (Q: Jun. 2021 )+Total Liabilities (Q: Jun. 2021 )
=68.071528751753+55.475455820477
=123.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allergy Therapeutics  (OTCPK:AGYTF) Total Assets Explanation

Total Assets is connected with ROA %.

Allergy Therapeutics's annualized ROA % for the quarter that ended in Jun. 2021 is

ROA %=Net Income (Q: Jun. 2021 )/( (Total Assets (Q: Dec. 2020 )+Total Assets (Q: Jun. 2021 ))/ count )
=-33.809256661992/( (133.0685483871+123.54698457223)/ 2 )
=-33.809256661992/128.30776647966
=-26.35 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2021) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Allergy Therapeutics's Asset Turnover for the quarter that ended in Jun. 2021 is

Asset Turnover
=Revenue (Q: Jun. 2021 )/( (Total Assets (Q: Dec. 2020 )+Total Assets (Q: Jun. 2021 ))/ count )
=42.495091164095/( (133.0685483871+123.54698457223)/ 2 )
=42.495091164095/128.30776647966
=0.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Allergy Therapeutics Total Assets Related Terms

Thank you for viewing the detailed overview of Allergy Therapeutics's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Allergy Therapeutics Business Description

Allergy Therapeutics logo
Industry
Traded in Other Exchanges
Address
Dominion Way, Worthing, West Sussex, GBR, BN14 8SA
Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergy with aluminium-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.

Allergy Therapeutics Headlines

No Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)